Neptune Technologies & Bioresources Inc Profit Margin 2009-2018 | NEPT
Current and historical gross margin, operating margin and net profit margin for Neptune Technologies & Bioresources Inc (NEPT) over the last 10 years. Profit margin can be defined as the percentage of revenue that a company retains as income after the deduction of expenses. Neptune Technologies & Bioresources Inc net profit margin as of December 31, 2018 is -60.48%.
Neptune Technologies & Bioresources Inc Annual Profit Margins |
---|
Neptune Technologies & Bioresources Inc Quarterly Profit Margins |
---|
Sector | Industry | Market Cap | Revenue |
---|---|---|---|
Medical | Medical Products Manufacturing | $0.293B | $0.022B |
Neptune Wellness Solutions Inc. operates as a nutrition supplement company. It develops and produces cannabis products, marine oils, seed oils and pet supplements. Neptune Wellness Solutions Inc., formerly known as Neptune Technologies & Bioressources Inc., is headquartered in Laval, Canada. |
Stock Name | Country | Market Cap | PE Ratio |
---|---|---|---|
Abbott Laboratories (ABT) | United States | $132.164B | 26.13 |
Medtronic (MDT) | Ireland | $123.923B | 18.53 |
Stryker (SYK) | United States | $69.625B | 25.56 |
Boston Scientific (BSX) | United States | $55.366B | 27.03 |
Baxter (BAX) | United States | $39.075B | 24.08 |
Zimmer Biomet Holdings (ZBH) | United States | $25.222B | 16.18 |
Smith & Nephew SNATS (SNN) | United Kingdom | $16.659B | 0.00 |
ResMed (RMD) | United States | $14.394B | 27.30 |
Canopy Growth (CGC) | Canada | $11.042B | 0.00 |
Bio-Rad Laboratories (BIO) | United States | $8.100B | 51.79 |
Aurora Cannabis (ACB) | Canada | $7.040B | 50.36 |
Hill-Rom Holdings (HRC) | United States | $6.974B | 21.57 |
Perrigo (PRGO) | Ireland | $6.650B | 10.09 |
Insulet (PODD) | United States | $5.226B | 0.00 |
ICU Medical (ICUI) | United States | $5.190B | 28.91 |
GW Pharmaceuticals (GWPH) | United Kingdom | $4.539B | 0.00 |
Haemonetics (HAE) | United States | $4.489B | 39.82 |
Agios Pharmaceuticals (AGIO) | United States | $3.462B | 0.00 |
Hutchison China MediTech (HCM) | China | $3.417B | 0.00 |
Neogen (NEOG) | United States | $3.281B | 50.39 |
NuVasive (NUVA) | United States | $3.013B | 28.03 |
National Vision Holdings (EYE) | United States | $2.624B | 50.75 |
Quidel (QDEL) | United States | $2.581B | 23.28 |
Aphria (APHA) | $2.402B | 106.67 | |
NxStage Medical (NXTM) | United States | $1.954B | 0.00 |
AtriCure (ATRC) | United States | $1.279B | 0.00 |
Phibro Animal Health (PAHC) | United States | $1.231B | 17.70 |
VAREX IMAGING (VREX) | United States | $1.198B | 23.45 |
Cardiovascular Systems (CSII) | United States | $1.170B | 840.00 |
MacroGenics (MGNX) | United States | $0.923B | 0.00 |
Cerus (CERS) | United States | $0.878B | 0.00 |
PetIQ (PETQ) | United States | $0.837B | 21.68 |
Surmodics (SRDX) | United States | $0.766B | 111.39 |
Evolus (EOLS) | United States | $0.747B | 0.00 |
NanoString Technologies (NSTG) | United States | $0.719B | 0.00 |
Lantheus Holdings (LNTH) | United States | $0.713B | 22.07 |
Meridian Bioscience (VIVO) | United States | $0.704B | 20.98 |
OraSure Technologies (OSUR) | United States | $0.703B | 31.03 |
Omeros (OMER) | United States | $0.688B | 0.00 |
Eagle Pharmaceuticals (EGRX) | United States | $0.625B | 20.05 |
Quanterix (QTRX) | United States | $0.505B | 0.00 |
LeMaitre Vascular (LMAT) | United States | $0.492B | 24.18 |
Owens & Minor (OMI) | United States | $0.479B | 5.42 |
TG Therapeutics (TGTX) | United States | $0.395B | 0.00 |
Insys Therapeutics (INSY) | United States | $0.368B | 0.00 |
Utah Medical Products (UTMD) | United States | $0.334B | 21.65 |
BioLife Solutions (BLFS) | United States | $0.299B | 404.00 |
Bovie Medical (APYX) | United States | $0.279B | 0.00 |
Vapotherm (VAPO) | United States | $0.276B | 0.00 |
Cytosorbents (CTSO) | United States | $0.262B | 0.00 |
Rockwell Medical (RMTI) | United States | $0.242B | 0.00 |
Zynex (ZYXI) | United States | $0.165B | 15.97 |
Surface Oncology (SURF) | United States | $0.150B | 0.00 |
Fonar (FONR) | United States | $0.143B | 7.65 |
Chembio Diagnostics (CEMI) | United States | $0.119B | 0.00 |
Chimerix (CMRX) | United States | $0.101B | 0.00 |
United-Guardian (UG) | United States | $0.091B | 18.98 |
Female Health (VERU) | United States | $0.084B | 0.00 |
CAS Medical Systems (CASM) | United States | $0.070B | 0.00 |
Trinity Biotech (TRIB) | Ireland | $0.063B | 17.33 |
Conatus Pharmaceuticals (CNAT) | United States | $0.062B | 0.00 |
Oramed Pharmaceuticals (ORMP) | United States | $0.056B | 0.00 |
ImmuCell (ICCC) | United States | $0.038B | 0.00 |
Neurotrope (NTRP) | United States | $0.034B | 0.00 |
Senestech (SNES) | United States | $0.021B | 0.00 |
Capricor Therapeutics (CAPR) | United States | $0.013B | 0.00 |
InVivo Therapeutics Holdings (NVIV) | United States | $0.013B | 0.00 |
Akers Biosciences Inc (AKER) | United States | $0.011B | 0.00 |
Valeritas Holdings (VLRX) | United States | $0.010B | 0.00 |
Cellectar Biosciences (CLRB) | United States | $0.009B | 0.00 |
NeuroMetrix (NURO) | United States | $0.007B | 13.57 |